Program

Corporate Workshops

Corporate Luncheon Workshops

The Corporate Luncheon Workshops are independent from the ISLH educational content. Please review the available workshops below and pre-register for any workshops that you wish to attend. There is no cost to attend these workshops. Corporate luncheon workshops are limited to meeting attendees. Details are subject to change.

How to Register

If you have already registered for the conference 
You may access the workshop registration system by logging into your account and clicking on the "Register Now" link in the Luncheon Workshop column of your conference registration record.

If you have not yet registered for the conference
Click here to first submit your conference registration. You will then be able to register for a luncheon workshop.

Corporate Luncheon Workshops


Thursday, May 10

(12:30 PM - 2:00 PM)


Success and clinical applications (Large Platelet Fraction and Body Fluid) of the Yumizen H2500/H1500, analytical cores of the HORIBA Medical Mid-High Hematology range of the HELO* Solution

Description: For over 30 years, HORIBA Medical teams have been working to develop solutions that meet the needs of medical laboratories and improving analyzers to provide more accurate diagnosis. In order to comply with the requirements and features of the mid-high size laboratories segment, HORIBA Medical has launched a new high range solution in hematology: the HELO* Solution. The analyzers Yumizen H2500 / H1500 and SPS (slide stainer) are the new analytical cores of this solution.

Speakers:

Ms Mandy Campbell, Sales and Marketing Manager, HORIBA UK, will share the successes and rewards experienced by the Torbay Hospital, UK, during the first installation of the HELO* Solution in the world during the last year.

Dr Sukesh Nair, MD, Professor and Director of Hematology, Christian Medical Center, Vellore, India, will then discuss the features of truly immature platelets and the new large platelet fraction (LPF) on the Yumizen H2500, that can be derived from both platelet impedance (PLT-I) and platelet optical extinction (PLT-Ox) parameters.  This LPF parameter not only correlates with the IPF, but more accurately reflects the patient platelet morphology.

Finally, Dr João Pego, MD, Hematology and Hemostasis Laboratory Manager, Clinical Pathology Department, Centro Hospitalar e Universitário de Coimbra, Coimbra, Portugal, will review the performance of the body fluid analysis on the YH2500 as his assessment of the clinical study in comparison with the DXH-800 and manual methods. The performance validation study, following CLSI H56 guideline, of the body fluid analysis on the Yumizen systems, will be discussed along with quality control material performance.




Sebia capillary electrophoresis: Breakthrough technology deserving your patients with hemoglobin disorders

Moderator: Pr. Cornelis L. HARTEVELD (Leiden University Medical Center, Leiden, The Netherlands)

Description: Fifty years after its creation, Sebia has become a key player in the diagnosis of hemoglobinopathies and thalassemias. The Sebia capillary electrophoresis is accessible to all laboratories and is a unique combination of ease of use, high resolution and high throughput. By attending this workshop, the audience will discover the medical added value offered by this breakthrough technology for hemoglobin disorders diagnosis.

Speaker: Mr. Jason EYRE (Royal Hallamshire Hospital, Sheffield, UK) will outline the drivers that led him to use capillary electrophoresis as a first line method for the screening of hemoglobinopathies and thalassemia and what are the advantages of using the CAPILLARYS 3 TERA, the next generation of Sebia multi-parametric capillary electrophoresis instruments. He will also demonstrate how the Sebia Hb A1c assay allows the incidental detection of these hemoglobin disorders during the follow-up or diagnosis of diabetic patients, and gives medical added values to the endocrinologists.

Speaker: Dr. Vip VIPRAKASIT (Siriraj Hospital, Mahidol University, Bangkok, Thailand) will demonstrate, with clinical clues, why capillary electrophoresis is a method of choice to screen the population for hemoglobinopathies and thalassemias, and especially the newborns. He will explain why capillary electrophoresis can be easily integrated in NBS strategy of a routine laboratory and how this technique can be helpful for supporting a long-term hemoglobinopathies and thalassemias prevention program, particularly in Thailand.


Friday, May 11

(12:30 PM - 2:00 PM)

Early Sepsis Indicator* (ESI)—A Novel Marker for Sepsis Detection in the Emergency Department

*CE-Marked. Pending clearance by the United States Food and Drug Administration; not yet available for in vitro diagnostic use in the U.S.

Description: The global burden of sepsis in healthcare, and the growing number of sepsis cases, signal an urgent need for better diagnostic testing that enables earlier detection of sepsis as well as infections that can lead to sepsis. Beckman Coulter’s workshop will be dedicated to ESI, the novel sepsis marker which is—for the very first time—available on routine hematology analyzers for any patient who has a CBC-Diff ordered.

Speakers:

Infection and Sepsis—Diagnostic Challenges for Laboratories and Clinicians
Professor Pierre Hausfater
Emergency Department, Sorbonne-Universités and AP-HP Groupe Hospitalier Pitié-Salpêtrière, France

Improved Detection of Sepsis in the Emergency Department with Early Sepsis Indicator
Vincent Esguerra, M.D.
Assistant Professor of Clinical Medicine, Division of Pulmonary, Critical Care and Sleep Medicine,
Ohio State Wexner Medical Center, United States

Analytical Performance of a Novel Sepsis Early Indicator, Monocyte Distribution Width (MDW)
Liliana Tejidor, Ph.D.
Senior Manager, Clinical Affairs, Beckman Coulter, United States

Multidisciplinary Reflex and Disease Management in Sepsis
Matthew Rhyner, Ph.D., MBA
Global Strategic Marketing Director, Hematology and Urinalysis,
Beckman Coulter, United States





Platelet Function Testing on Routine Coagulation Analyzers using Light Transmission Aggregometry (LTA): Atellica COAG 360 and Sysmex® CS-2500 Systems

Speaker: Priv.-Doz. Dr. med. univ. Florian Prüller, University Hospital Graz, Graz, Austria

Description: Laboratory tests are important to diagnose platelet function disorders, which are present in acquired and inherited bleeding disorders. For the assessment of platelet aggregation a broad range of agonists including ADP, arachidonic acid, collagen, epinephrine, and ristocetin, thrombin is commonly used allowing the classification of the diverse platelet function disorders. However, measurement of platelet function is time consuming and technically challenging influenced by pre-analytical and analytical factors variables as well as the lack of standardization and automation.

To provide an easy and high-throughput application on-board a standard routine coagulation analyzer (without the need for specific and complex additional equipment) platelet aggregation applications have been implemented in the fully-automated routine coagulation analyzer systems Atellica COAG 360 and Sysmex CS-2500.

Results of the comparison between the automated and manual stand-alone light transmission aggregometry systems based on Gustav Born’s principle will be presented.

Platelet function measurements performed with the Atellica COAG 360 and the Sysmex CS-2500 system allow for an easy automated and high-throughput platelet function testing, resulting in a reduction of hands-on time and establishing a new era of standardization and harmonization.




Unlimited Possibilities in Haematology

Speakers:
Dr. Francoise Schillinger, Besançon, France
Dr. Patrick Cohen, Geneva, Switzerland
Dr. Marion Munster, Sysmex Europe GmbH

Description: Clinical laboratories, while having to provide correct and clinically useful information, must also control their costs. For example, it is not acceptable to miss a malignant monocytosis but smear review often reveals a monocytosis of reactive origin, for which morphological review does not add any useful information. Consequently, the laboratory is faced with the uncomfortable decision between performing unnecessary smear reviews or increasing the monocytosis cut-off including the risk of missing malignant samples. An advanced solution for the differentiation between malignant and reactive monocytosis has recently been developed and will be presented. Another issue causing a lot of manual work are samples with increased MCHC values. Sysmex recently launched the CBC-O application to help laboratories deal with such samples, and the first experiences in laboratory routine will be shared. Clinical laboratories are service providers to their customers – the clinical wards. A growing concern of public health is the rise of pathogens that are resistant to common medications. It is therefore of utmost importance that the laboratory provides the wards with accurate information about the presence of an infection. Recent studies could show that haematology analysers can play a big role in this, which will be discussed.


Saturday, May 12

(12:00 PM - 1:30 PM)



The Alinity h-series system: Advanced Optical Technology for Elevated Analytical Performance

Title: Case reviews using the advanced optical technology of the Alinity h-series
Speaker: Zainab Mukhtar, MD, Manager, Medical and Scientific Affairs, Abbott Hematology
Description: The Alinity hq is a fully optical hematology analyzer that reports a complete blood count (CBC) with a 6-part white blood cell differential, which includes immature granulocytes (IGs). The system employs a new and advanced version of MAPSS technology, developed based on machine learning algorithms to provide enhanced differentiation of blood cells. In addition, analysis of red blood cells and platelets are performed using entirely optical technology, allowing for the introduction of additional parameters. In this presentation, Dr. Mukhtar will review the general principles and capabilities of the Alinity hq analyzer, and review a series of cases produced by the system.

Title: The analytical performance of the Alinity h-series system: Results from a multi-center evaluation
Speaker: Panel Discussion led by Gabriella Lakos, MD, PhD, D (ABLMI), Senior Associate Medical Director, Abbott Hematology
Description: During this symposium, performance of the Alinity h-series system as compared to the CELL-DYN Sapphire and manual differential results from three sites in the Netherlands will be reviewed. Analytical characteristics, such as repeatability and reproducibility across three sites for both normal and pathological samples, and performance data and observations will be discussed.
Product not available in all markets, including US.





Hematology diagnostics reinvented – How are new imaging techniques fitting into current practice?

Speakers:
Parul Bhargava, MD (Chair) University of California San Francisco (UCSF) California, USA
Jasper Remijn, PhD Department of Clinical Chemistry and Hematology, Gelre Hospitals Apeldoorn, The Netherlands
Henk Russcher, PhD Department of Clinical Chemistry, Erasmus MC Rotterdam, The Netherlands
Mathias Bruegel, MD Institute of Laboratory Medicine, University Hospital, LMU Munich, Germany

Description: Instrumentation used in hematology diagnostics has advanced in recent decades but is still limited with regards to imaging cellular components, resulting in additional specimen handling and microscopic manual review by skilled operators. Recently, a novel, automated, image-based approach using a slide preparation technique has been developed. This novel technology, which uses digital imaging to allow precise simultaneous counting of blood cells and analysis of morphology and cell classification, provides a comprehensive and faster analysis of blood samples than conventional methods and facilitates cross-laboratory standardization.

In this ISLH workshop, Dr Jasper Remijn will share his thoughts regarding the current challenges in hematology diagnostics. This will be followed by a presentation from Dr Henk Russcher, who will describe this novel, image-based technology, and present his experience of using this approach as part of a multicenter clinical trial. Dr Mathias Bruegel will then discuss the clinical value of automated hematology analyzers, with respect to different technologies and clinical settings. Following these presentations, Dr Parul Bhargava will lead a Q&A session in order to further interrogate the data presented and better understand the implications of this novel technology in everyday laboratory practice.